Selecting effective antisense target sites on a given mRNA molecule constitutes a major problem in antisense therapeutics. By trial-and-error, only 1 in 18 (6%) of antisense oligonucleotides designed to target the primary RNA transcript of tumor necrosis factor-␣ (TNF-␣) strongly inhibited TNF-␣ synthesis. Subsequent studies showed that the area in RNA targeted by antisense oligonucleotides could be moved effectively 10 -15 bases in either direction from the original area. We observed that only molecules that incorporated a tetranucleotide motif TCCC (complementary to GGGA on RNA) yielded potent antisense oligonucleotides against TNF-␣. A comprehensive literature survey showed that this motif is unwittingly present in 48% of the most potent antisense oligonucleotides reported in the literature. This finding was prospectively used to predict the sequences of additional antisense oligonucleotides for the rat TNF-␣ primary RNA transcript. Over 50% of antisense constructs (13 of 22) containing the TCCC motif were found to effectively inhibit TNF-␣ synthesis. Marked reductions in mRNA were also observed. This motif was found to be most effective when targeting introns in the primary RNA transcript, suggesting a nuclear localization for the antisense action. Predicting target sites based on the presence of this motif in primary RNA transcripts should be of value in the development on new antisense pharmacotherapy.
Selecting effective antisense target sites on a given mRNA molecule constitutes a major problem in antisense therapeutics. By trial-and-error, only 1 in 18 (6%) of antisense oligonucleotides designed to target the primary RNA transcript of tumor necrosis factor-␣ (TNF-␣) strongly inhibited TNF-␣ synthesis. Subsequent studies showed that the area in RNA targeted by antisense oligonucleotides could be moved effectively 10 -15 bases in either direction from the original area. We observed that only molecules that incorporated a tetranucleotide motif TCCC (complementary to GGGA on RNA) yielded potent antisense oligonucleotides against TNF-␣. A comprehensive literature survey showed that this motif is unwittingly present in 48% of the most potent antisense oligonucleotides reported in the literature. This finding was prospectively used to predict the sequences of additional antisense oligonucleotides for the rat TNF-␣ primary RNA transcript. Over 50% of antisense constructs (13 of 22) containing the TCCC motif were found to effectively inhibit TNF-␣ synthesis. Marked reductions in mRNA were also observed. This motif was found to be most effective when targeting introns in the primary RNA transcript, suggesting a nuclear localization for the antisense action. Predicting target sites based on the presence of this motif in primary RNA transcripts should be of value in the development on new antisense pharmacotherapy.
Antisense oligonucleotides (ASOs) 1 are short synthetic deoxyribonucleic acids designed to bind to specific sequences in mRNA by Watson-Crick base pairing. They have been widely used to inhibit the expression of genes involved in cancer, inflammatory diseases and viral infections (1) . Over 10 ASOs are now undergoing human clinical trials (2, 3) .
One of the major obstacles to applying ASOs for therapeutic or research purposes is the selection of target sites from a given mRNA sequence (4, 5) . The best sequences in an mRNA molecule for antisense targeting have been selected mainly by empirical screening of large numbers of oligonucleotides (see references in Table IV) .
In order to facilitate the process of selecting suitable target sites for the antisense action, several strategies have been proposed. The first strategy is based upon binding energy. Chiang et al. (6) designed 10 ASOs with maximal melting temperature (T m ). However, they found that the most active ASO exhibited a T m that was lower than that of the majority of the other tested ASOs. Stull et al. (7) tried to develop a systematic approach for predicting potent target sites and found that the D score , which estimates the ⌬G formation for the ASO-mRNA duplex, was the most consistent predictor of ASO efficacy in four of the five reported studies, while the results of the fifth could not be predicted by any thermodynamic or physical index. The second strategy for selecting suitable target sites is based upon the secondary structure of mRNA. The results obtained by Lima et al. (8) and by Thierry et al. (9) showed that single-stranded loops of hairpin structures in RNA were the best target sites. However, studies by Laptev et al. (4) suggested that the most potent ASOs were those targeted to the sequences that were predicted to form clustered doublestranded structures in RNA transcripts. Based upon these mixed results, Lima et al. (10) concluded that the number of structurally ideal RNA hybridization sites is so limited that obtaining effective ASOs as long as 20-mer is improbable. Recently, two novel methodologies were developed to choose potent ASOs. Ho et al. (11, 12) and Lima et al. (10) used libraries of semi-random or random oligodeoxynucleotides to map the areas along mRNA that can form DNA-RNA hybrids, which become accessible to RNase H. Milner et al. (13) used an array of 1,938 oligonucleotides on a glass plate to measure the potential of oligonucleotides for the heteroduplex formation with the target transcript. These methods are elegant, but laborious and complex. If potent ASO drugs are sought, it is imperative to develop knowledge to predict the most effective target sites for ASO design.
TNF-␣ is a proinflammatory cytokine, which exhibits pleiotropic effects on various cell types and tissues (14) . Kupffer cells, the resident hepatic macrophages, are major producers of TNF-␣, particularly after exposure to bacterial lipopolysaccharide (LPS) (15) . Local production of TNF-␣ is essential for homeostasis, but its overproduction has been linked to many inflammatory conditions, such as rheumatoid arthritis (16) , multiple sclerosis (17) , inflammatory bowel disease (18) , allograft rejection (19) , septic shock (20) , fetal cerebral malaria (21) , and human immunodeficiency virus infection. A number of studies have shown that the levels of TNF-␣ are greatly elevated in the plasma of patients with alcoholic hepatitis and cirrhosis, and highly correlated with mortality (22, 23) . Efforts to inhibit the overproduction of TNF-␣ would be of value in the treatment of a number of inflammatory diseases.
EXPERIMENTAL PROCEDURES
Oligonucleotides-All phosphorothioate-modified ASOs used in this study were synthesized by Genset (La Jolla, CA). For cell treatment, the ASOs were sterilized by filtration through 0.45-m filter (Corning, Corning, NY) and stored at Ϫ70°C prior to use.
Kupffer Cell Preparation-Kupffer cells were isolated from male Sprague-Dawley rats (300 -400 g) by sequential digestion of the liver with Pronase and type I collagenase followed by elutriation as described by Bautista et al. (24) . The purity of Kupffer cells assessed by peroxidase enzymatic stain and latex bead (1 m) phagocytosis was more than 90%. The viability assessed by the trypan blue dye exclusion test was more than 90%. Kupffer cells were seeded at 1 ϫ 10 6 cells/35-mm dish (for inhibition tests) or 10 ϫ 10 6 cells/100-mm dish (for mRNA determinations), and further purified by the adherence method as described by Kamimura and Tsukamoto (25) . The cells were typically incubated in RPMI medium with 10% fetal bovine serum for 1-2 days following the adherence prior to in vitro experiments.
Bioassay-The TNF-␣ bioassay was performed according to Kamimura and Tsukamoto (25) by using the WEHI 164 cell line (ATCC, Rockville, MD). All samples were assayed in triplicate, and the standard deviation for each group was determined.
Enzyme-linked Immunoabsorbent Assay (ELISA)-ELISA was conducted by using Cytoscreen KRC3012 kits (Biosource, Camarillo, CA) according to the manufacturer's specifications. Supernatants containing high TNF-␣ level were diluted prior to the assay to assure assay results within the standard curve.
Delivery-ASOs were delivered into cultured rat Kupffer cells by cationic liposomes (LipofectAMINE; Life Technologies, Inc.) at a concentration of 8 g/ml for 4 h as described previously (26) . After being cultured for another 17 h, the cells were stimulated with 1 g/ml LPS for 2 h. The culture medium was then removed and stored at Ϫ70°C for TNF-␣ assay.
Northern Hybridization-The total cellular RNA was isolated as described previously (26) . A Northern blot was prepared with 5 g of total RNA/lane and probed with 32 P-labeled cDNA of murine TNF-␣ as described by Kamimura and Tsukamoto (25) . The data on densitometric analysis of TNF-␣ mRNA level were standardized by those of 18 S rRNA hybridization and compared between the treated and untreated cells.
RESULTS

Screening of Potent ASOs by
Trial-and-Error-In our initial work aimed at developing potent ASOs for TNF-␣, we screened 18 19 -21-mer phosphorothioate-modified ASOs by a trial-anderror method. Sixteen of them were designed to target different functional regions on the TNF-␣ primary RNA transcript before the AATAAA polyadenylation site, including the putative transcription start point, the translation initiation codon AUG, splicing sites, the stop codon, and 3Ј-untranslated region (3Ј-UTR), while two of them were designed to target the sequence after the AATAAA polyadenylation site (27) (Fig. 1) . Table I lists all the sequences and T m of designed ASOs. These ASOs were examined at a concentration of 1 M for their ability to inhibit the production of TNF-␣ by cultured rat Kupffer cells after LPS stimulation. The TNF-␣ production was determined first by bioassay, and the results were confirmed by ELISA. All ASOs were delivered into the cultured cells by cationic liposomes. Cationic liposomes have been shown by us (26) and by others (28, 29) to enhance the cellular uptake of phosphorothioate-modified ASOs. Although cationic liposomes, at high concentrations, have been reported to have toxicity and immunomodulatory activity (30) , treatment of the cultured rat Kupffer cells with LipofectAMINE or Superfect at a concentration of 8 g/ml (4 nmol/ml) for 4 h was found to affect the cell viability and TNF-␣ production by less than 15%. To normalize for these effects, all the tests consisted of a group of controls that contain liposomes alone. After delivery, the ASO/liposome complex was removed from the extracellular compartment and the cells were washed twice with culture medium. The medium was then kept free of both ASO and liposomes during both LPS stimulation and TNF-␣ assay periods to avoid false results (29, 31) .
As shown in Fig. 2 , only one ASO, TJU-2755, designed to target the 3Ј-UTR of the primary RNA transcript, was found to strongly inhibit the TNF-␣ production. In the presence of TJU-2755, TNF-␣ production was inhibited by 90%, compared with control values for liposomes alone. Another ASO, TJU-0796, designed to target the fragment spanning the AUG codon, was also able to inhibit the TNF-␣ production but showed less efficacy (50% inhibition). The remaining ASOs, including those designed to target the fragments starting from the AUG codon (TJU-0807) or containing the UUAUUUAUU motif (TJU-2927) which has been proposed to be involved in the rapid degradation of cytokine mRNAs (32), had no effect or activated the TNF-␣ production. The inhibition of the TNF-␣ production by both TJU-2755 and TJU-0796 is dose-dependent, with an I 50 value (the concentration at which ASOs cause a 50% of inhibition) of approximate 100 and 700 nM, respectively (Fig. 3) .
To test the specificity of the inhibition of TJU-2755 on the TNF-␣ production, two controls were examined at higher concentration (2 M): a scrambled oligonucleotide TJU-2755RD (same nucleotide composition in random order) and a sense oligonucleotide TJU-2755SS (complementary to the antisense). After being delivered into the cells, both of control oligonucleotides were found to have no effect on the TNF-␣ production in the cells (Fig. 2) , indicating that the inhibition induced by Lines between exons are introns. The transcription start point (tsp), translation initiation codon AUG, stop codon, and AATAAA polyadenylation site are indicated below the line. The area before AUG is the 5Ј-UTR, and the area after the stop codon is the 3Ј-UTR. The 18 ASO target sites are indicated above the line by four-digit numbers, which also represent the ASO's name (see Table I ). Novel Target Site for Antisense DesignTJU-2755 on TNF-␣ production is markedly dependent on oligonucleotide sequence.
To determine whether the target sites for most effective antisense inhibition of the TNF-␣ production were located in a narrow or a wide region on the 3Ј-UTR of the primary RNA transcript, another 10 ASOs were designed by moving the 5Ј-end of the target sequence of TJU-2755 by 3 nucleotides each time upstream or downstream (Table II) . It was revealing that (a) an approximately 40-base-long fragment on the 3Ј-UTR of the primary transcript is an effective target area for the antisense action, and (b) all the potent ASOs contained the TC-CCCC motif, which is complementary to the GGGGGA motif on the 3Ј-UTR of the primary transcript (Table II) . The potent ASOs could be shortened to 15-mer while retaining the same inhibitory ability as their parent 21-mer (data not shown), provided these incorporated the above motif. It should be noted that it is the target sites rather than the antisense constructs which contain the G-tetrad structure, which has been reported to yield nonspecific effects when present in ASOs (33) .
Two questions arose from these results. 1) What is the minimal length in the TCCCCC motif required for potent ASOs? 2) Is this motif only specific for rat TNF-␣ mRNA, or does it also exist in other ASO constructs?
Comprehensive Literature Survey-To answer the above questions, we conducted a comprehensive reference search with the aid of Medline to compare the sequences of the most effective versus the less effective or ineffective ASOs reported in the literature to September 1997. As shown in Table III , most studies (82%) reported just a single ASO construct, or at best two or three ASOs (12%) for the targeted mRNA. Thus, it is difficult to determine that these were indeed the most effective ASOs that could have been designed for their respective mRNAs. It should also be noted that, among these, 59% of ASOs were designed to target the translation initiation AUG codon, which is common for all proteins, or part of the coding region downstream from it.
To impose stringent conditions on the analysis, we imposed the requirement that the most effective antisense construct should be chosen from at least 10 or more ASOs designed to target a broad range, rather than particular regions, of the respective mRNA, or alternatively that these ASOs should be in use in the FDA-approved human clinical trials by pharmaceutical companies, which are unlikely to give the rationale for the choice of their most successful ASOs. A total of 42 ASOs complied with these conditions. We found that the tetranucleotide TCCC motif was contained in 20 of the 42 most effective ASOs (47.6%). Table IV gives all the sequences of the most effective ASOs containing the tetranucleotide TCCC motif we found in the literature. The sequences of the most effective ASOs, which do not contain the TCCC motif, are not listed, but they can be provided on request. A chi-square analysis indicates that the probability of one TCCC motif existing by chance in 20 of 42 ASOs is p Ͻ Ͻ 0.001 ( 2 ϭ 34.8). When the TCCC motif is compared with the XCCC motif with an A, G, or C but Fig. 1 and Table I ), and two control oligonucleotides (2755-SS (sense) and 2755-RD (scrambled)) were separately delivered at a concentration of 1 M into cultured rat Kupffer cells by cationic liposomes (8 g/ ml). After LPS (1 g/ml) challenge for 2 h, the media were collected for TNF-␣ determination as described under "Experimental Procedures." The data are plotted as the average % (Ϯ S not T as X, the sequence was only found in 5 of the 42 most effective ASO sequences. Thus, the complete TCCC motif, flanked by the oligonucleotide complementary to the targeted mRNA, is typical for highly effective ASOs (only in two cases were a terminal TCCC present in an effective ASO) (Table IV) . This finding allows a new strategy for the selection of potent ASOs.
Prediction of Potent ASOs by Targeting the GGGA Motif in the Rat TNF-␣ Primary RNA Transcript-From the sequence of the rat TNF-␣ gene published by Shirai et al. (27) , there are 28 GGGA motifs in the primary transcript before the AATAAA polyadenylation site and another 3 in the sequence after that site. As shown in Fig. 4 , these motifs are distributed in introns 1-3, exon 4, and both 5Ј-and 3Ј-UTR but not in exons 1-3. To test validity of the above finding, we designed a new series of ASOs to target all GGGA motifs. Table V lists the sequences of all the newly designed ASOs plus TJU-2740 and TJU-2755, which were tested before (see Table II and Fig. 2 ). Among 25 ASOs, 6 targeted the RNA areas containing two adjacent GGGA motifs while the rest were designed to target the fragments containing only one GGGA (see Fig. 4 and Table V) . Another four ASOs, which contain the TCCC motif but were designed for separate studies to target the mRNA of rat inducible nitric-oxide synthase, were used as "motif controls" (Table   TABLE II Novel Target Site for Antisense DesignV). All the ASOs were examined for their inhibitory abilities on the TNF-␣ production at a concentration of 1 M. As shown in Fig. 5, among 22 ASOs, which were designed to target the fragments containing the GGGA motif before the AATAAA polyadenylation site, 13 were found to be able to inhibit the TNF-␣ production by 75% or more, indicating a 60% success rate of prediction. The ASOs, which were designed to target the fragments containing the GGGA motif after the AATAAA polyadenylation site, were found inactive. The four inducible nitric-oxide synthase ASOs, all of which contain the TCCC motif, did not inhibit the TNF-␣ production (data not shown), indicating that the TCCC motif alone does not cause an inhibition of TNF-␣ production but rather that the motif should be contained in a sequence that is complementary to the primary RNA transcript of TNF-␣ gene.
The Mechanism of Action of ASOs-To determine the mechanism of action of ASOs containing the TCCC motif, the cultured rat Kupffer cells were incubated with 1 M ASOs. Total cellular RNA was isolated from both treated and untreated cells, and the steady-state levels of rat TNF-␣ mRNAs were determined by Northern hybridization. Seven ASOs were chosen for the analysis: two (TJU-0796 and -2755) from the trialand-error screening and five (TJU-1906, -2350, -3004, -3208 , and -3466) from the prediction experiment. As shown in Fig. 6 , the most potent ASOs (TJU-2755, -1906, and -3004 ; see Figs. 1, 2, 4 and 5), targeted to areas containing the GGGA motif in the primary transcript, markedly reduced the LPS-induced rat TNF-␣ mRNA levels, suggesting that the inhibition of these potent ASOs on the TNF-␣ production results from mechanisms in which the ASOs either promote the degradation of the target mRNA or interfere with transcription. In contrast, the active ASO TJU-0796, which was designed to target the AUG codon of the primary RNA transcript (see Figs. 1 and 2) , did not change the steady-state level of the mRNA, implying that this ASO inhibits the TNF-␣ production by a translational arrest mechanism (6) . As expected, the inactive ASOs (TJU-2350, -3208, and -3466; see Figs. 1, 2, 4, and 5) had no effect on the mRNA levels.
DISCUSSION
Theoretically, any region of an mRNA could be targeted by ASOs. However, only a few of particular areas in an mRNA molecule have been reported to be suitable target sites for ASO action (see references in Table IV ). The factors which influence antisense potency are poorly understood. Many regions may not be accessible for ASOs because of the secondary and tertiary structures of mRNA, and other regions may not provide enough binding energy for antisense hybridization. Therefore, it has been proposed that the mRNA targeting is unpredictable (11, 51) and the selection of suitable target sites for the antisense action still remains in the trial-and-error stage.
In our initial studies, we screened 18 ASOs, which were designed to target the different functional regions of the rat TNF-␣ primary transcript. Among them, only one ASO (TJU-2755), designed to target the 3Ј-UTR, was found to be able to inhibit the production of TNF-␣ by 90%, determined by both bioassay and ELISA. This inhibition is sequence-specific (Fig.  2) and dose-dependent (Fig. 3) . Two control oligonucleotides, sense oligonucleotide TJU-2755SS and scrambled oligonucleotide TJU-2755RD showed no inhibition on the TNF-␣ production. Another ASO (TJU-0796), designed to target the translation initiation codon AUG, was effective but showed less efficacy (maximum inhibition was 50%) and a higher I 50 . Other designed ASOs either exhibited no inhibition or activated the TNF-␣ production, even though some of these have higher T m values than the most effective ASO TJU-2755. This low success rate for the selection of potent ASOs by the trial-and-error method is consistent with those obtained by other laboratories (see references in Table IV) .
In contrast to empirical screening, designing ASOs by targeting the fragments containing GGGA motif, as presented in this study, has a much higher success rate. As shown in Fig. 5 , 60% (13/22) of ASOs incorporating the TCCC motif were able to inhibit the TNF-␣ production by 75% or more. This is in line with the 50% success rate found in the review of the literature for all antisense studies (Table IV) . The reduction of the steadystate levels of the TNF-␣ mRNA, caused by the treatment of these effective ASOs containing TCCC motif, suggests that the inhibition results from mechanisms in which the ASOs promote the degradation of the target mRNA or interfere with transcription. The fact that most of the successful constructs target GGGA-containing areas in primary transcripts suggest that the effect is exerted in the nucleus, before the message is A total of 25 ASOs were designed to target 31 GGGA motifs. Among them, six were designed to target fragments containing two adjacent GGGA motifs while the rest were designed to target the fragments containing only one motif (see Table V ). Giles et al. (52) have indicated that RNase H is located in the nucleus, and oligonucleotides introduced directly into the cell cytoplasm by microinjection, electroporation, streptolysin O treatment, or cationic liposome delivery rapidly accumulate in the nucleus. Therefore, ASOs, RNases, and newly synthesized mRNA molecules (primary transcripts) are present in the same subcellular compartment. Thus, it is reasonable to propose that the nucleus, rather than the cytoplasm, is the main location for the antisense action, and that primary transcripts rather than the mature mRNAs should be the target, if the mechanism of action for ASO is the degradation of mRNA by nuclear RNases. Mature mRNA could be the target in the cytoplasm, only if ASOs bind to mature mRNA before they accumulate in the nucleus, and the translation is stopped by ASO by a translation-arrest mechanism. This inhibition may be less effective because oligonucleotides do not remain in the cytoplasm and mRNA adopts a stable secondary structure. Unfortunately, most of ASOs reported in the literature were designed to target mature mRNAs, not primary transcripts, and 70% of them were only designed to target the AUG codon, although it has been proposed that ASOs could attack mRNAs at different stages of post-transcription (53) . In the present study, the ASOs were designed to target the primary transcript of the rat TNF-␣ gene. It was found that the most effective ASOs containing the TCCC motif are located in the 3Ј-and 5Ј-UTR, and introns but not in exon 4 (other exons do not contain the GGGA motif). The ASOs, which were deigned to target the fragments either bridging (TJU-0796) or starting from the AUG codon (TJU-0807), were found less effective or ineffective.
It is likely that the tetranucleotide motif GGGA is one of suitable target sites on the primary transcript molecule not only for the rat TNF-␣ mRNA but also for other mRNAs. Our recent work has further shown that the GGGA motif is also a good target site for the antisense action against the mRNAs of mouse TNF-␣, 2 and both rat and mouse inducible nitric-oxide synthase. 2 Design of ASOs by this method seems to be simple, economic, and effective. Prediction of suitable target sites based on this method should be of value in the design of antisense pharmacotherapy.
Although the data base obtained by the prospective prediction is too small to generalize across different gene transcripts, the results from the retrospective literature survey are very encouraging since the TCCC motif existed in 47.6% of the most effective ASOs reported in the literature (Table IV) . These ASOs were empirically screened by different laboratories to target different mRNAs from different species.
It remains to be elucidated why there is a high prevalence of the tetranucleotide motif TCCC in the most potent ASOs reported in the literature.
We suppose that the regions containing the GGGA motif may be the preferred sites for RNase digestion. This hypothesis is supported by the observations of Lima and Crooke (54) indicating that, although RNase H was reported to have a broad specificity toward the sequence of DNA-RNA hybrid, it preferentially binds to the A-form DNA-RNA duplex. Since RNA sequences containing high purine content are predicted to stack in the A-form conformation (55), they suggested that RNase H activity may be improved with ASOs containing pyrimidine-rich sequences. It is interesting that, aside from TCCC motif itself, the bases at the both sides of the motif in the most potent ASO constructs are indeed pyrimidine-rich (Table V) .
Besides RNase H, there are other RNases in the nucleus, some of them cut the single RNA strand adjacent to DNA-RNA duplex. The enzymatic properties of these RNases, including the specificity, have not been studied. We suppose that they may have strong specificity toward the GGGA motif either in the RNA strand of DNA-RNA duplex or in the single RNA strand adjacent to DNA-RNA hybrid. Twenty-five ASOs, designed to target the fragments containing the GGGA motif on the rat TNF-␣ primary transcript (see Fig. 4 and Table V) , were separately delivered into cultured rat Kupffer cells and examined as described in Fig. 2 . Of the 25 ASOs, three control constructs targeted GGGA motifs downstream from the polyadenylation site. These are shown on the extreme right (TJU-3466, TJU-3484, and TJU-3499). 
